Brucke Financial’s Thermo Fisher Scientific TMO Stock Holding History

Brucke Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-431	Closed	-$250K	–	201
2025 Q4	$250K	Buy	431 +6	+1%	+$3.39K	0.14%	137
2025 Q3	$241K	Buy	+425	New	+$198K	0.14%	132
2025 Q1	–	Sell	-424	Closed	-$253K	–	144
2024 Q4	$253K	Buy	+424	New	+$233K	0.22%	111

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brucke Financial's TMO Position: Q1 2026 in Review

Brucke Financial sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 431 shares — an estimated $250K sold.

Brucke Financial first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $253K in Q4 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Brucke Financial reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Brucke Financial sold 431 Thermo Fisher Scientific shares in Q1 2026, an estimated $250K.
Brucke Financial first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
Brucke Financial's Thermo Fisher Scientific position peaked at $253K in Q4 2024.
2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Brucke Financial's 13F filing for Q1 2026, filed 10 Apr 2026.